29 Feb 2024
// PRESS RELEASE
11 Jun 2023
// PRESS RELEASE
03 Nov 2022
// PRESS RELEASE
Latest Content by PharmaCompass
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
About
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Industry Trade Show
Not Confirmed
11-13 November, 2024
CONTACT DETAILS
Events
Webinars & Exhibitions
Severity: Warning
Message: Undefined variable $tile1
Filename: tabs/exhibitions.php
Line Number: 43
Backtrace:
File: /var/www/html/application/views/include/party/inc/tabs/exhibitions.php
Line: 43
Function: _error_handler
File: /var/www/html/application/models/CmnPec.php
Line: 1625
Function: view
File: /var/www/html/application/views/include/party/query.php
Line: 575
Function: create
File: /var/www/html/application/views/include/party/indexNew.php
Line: 70
Function: include
File: /var/www/html/application/views/commonNew.php
Line: 445
Function: include
File: /var/www/html/application/controllers/PharmaServices.php
Line: 4640
Function: view
File: /var/www/html/index.php
Line: 224
Function: require_once
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Industry Trade Show
Not Confirmed
11-13 November, 2024
CORPORATE CONTENT #SupplierSpotlight
29 Feb 2024
// PRESS RELEASE
https://www.pharmathen.com/news/Pharmathen-fully-equips-the-new-scientific-laboratory-of-the-3rd-Gymnasium-of-Gerakas
11 Jun 2023
// PRESS RELEASE
03 Nov 2022
// PRESS RELEASE
23 Aug 2022
// Joshua Silverwood JUVE
https://www.juve-patent.com/news-and-stories/cases/dutch-court-halts-sale-of-pharmathen-cancer-drug-okrodin-in-europe/
08 Aug 2022
// PRESS RELEASE
GDUFA
DMF Review : Complete
Rev. Date : 2018-03-20
Pay. Date : 2017-11-15
DMF Number : 32203
Submission : 2017-12-06
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-12-06
Pay. Date : 2019-10-21
DMF Number : 34167
Submission : 2019-10-07
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24091
Submission : 2010-08-20
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-02-27
Pay. Date : 2016-12-01
DMF Number : 31062
Submission : 2016-12-27
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-11-07
Pay. Date : 2017-04-28
DMF Number : 31546
Submission : 2017-05-12
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-07-11
Pay. Date : 2017-04-28
DMF Number : 31545
Submission : 2017-05-10
Status : Active
Type : II
Details:
On acquisition, Partners Group will work to strengthen Pharmathen’s business in Europe and the US, especially R&D, sustained release’ technologies, including long-acting injectables, slow-releasing oral drugs and ophthalmics segment.
Lead Product(s): Undisclosed
Therapeutic Area: Ophthalmology Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Small molecule
Sponsor: Partners Group
Deal Size: $1,900.0 million Upfront Cash: Undisclosed
Deal Type: Acquisition July 19, 2021
Lead Product(s) : Undisclosed
Therapeutic Area : Ophthalmology
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Partners Group
Deal Size : $1,900.0 million
Deal Type : Acquisition
Partners Group to Acquire Pharmathen, a Leading European Pharmaceutical Company, from BC Partners
Details : On acquisition, Partners Group will work to strengthen Pharmathen’s business in Europe and the US, especially R&D, sustained release’ technologies, including long-acting injectables, slow-releasing oral drugs and ophthalmics segment.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
July 19, 2021
Regulatory Info : EU Approved
Registration Country : Greece
Alendronate Sodium; Vitamin D3
Dosage Form : Tablet
Brand Name :
Dosage Strength : 70MG; 5600IU
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info : EU Approved
Registration Country : Greece
Alendronate Sodium; Vitamin D3
Dosage Form : Tablet
Brand Name :
Dosage Strength : 70MG; 2800IU
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info : EU Approved
Registration Country : Greece
Dosage Form : Hard Capsule
Brand Name :
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info : EU Approved
Registration Country : Greece
Dosage Form : Hard Capsule
Brand Name :
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info : USA
Registration Country : Greece
Dosage Form : Injectable Emulsion, For...
Brand Name :
Dosage Strength : 130MG
Packaging : Single Dose Vial
Approval Date :
Application Number :
Regulatory Info : USA
Registration Country : Greece
Regulatory Info : EU Approved
Registration Country : Greece
Dosage Form : Hard Capsule
Brand Name :
Dosage Strength : 80MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info : EU Approved
Registration Country : Greece
Dosage Form : Hard Capsule
Brand Name :
Dosage Strength : 165MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info : EU Approved
Registration Country : Greece
Dosage Form : Tablet
Brand Name :
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info : EU Approved
Registration Country : Greece
Dosage Form : Tablet
Brand Name :
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info : EU Approved
Registration Country : Greece
Dosage Form : Orodispersible Tablet
Brand Name :
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info : EU Approved
Registration Country : Greece
Alendronate Sodium; Vitamin D3
Dosage Form : Tablet
Brand Name :
Dosage Strength : 70MG; 2800IU
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info : EU Approved
Registration Country : Greece
Alendronate Sodium; Vitamin D3
Dosage Form : Tablet
Brand Name :
Dosage Strength : 70MG; 5600IU
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info : EU Approved
Registration Country : Greece
Dosage Form : Hard Capsule
Brand Name :
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info : EU Approved
Registration Country : Greece
Dosage Form : Hard Capsule
Brand Name :
Dosage Strength : 80MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info : EU Approved
Registration Country : Greece
Dosage Form : Hard Capsule
Brand Name :
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info : EU Approved
Registration Country : Greece
Dosage Form : Hard Capsule
Brand Name :
Dosage Strength : 165MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info : USA
Registration Country : Greece
Dosage Form : Injectable Emulsion, For Int...
Brand Name :
Dosage Strength : 130MG
Packaging : Single Dose Vial
Approval Date :
Application Number :
Regulatory Info : USA
Registration Country : Greece
Regulatory Info : EU Approved
Registration Country : Greece
Dosage Form : Orodispersible Tablet
Brand Name :
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info : EU Approved
Registration Country : Greece
Dosage Form : Orodispersible Tablet
Brand Name :
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info : USA
Registration Country : Greece
Dosage Form : Long Acting Injectable
Brand Name :
Dosage Strength : 300MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : USA
Registration Country : Greece
Inspections and registrations
ABOUT THIS PAGE
Pharmathen SA is a supplier offers 6 products (APIs, Excipients or Intermediates).
Find a price of Aprepitant bulk with DMF offered by Pharmathen SA
Find a price of Brinzolamide bulk with DMF offered by Pharmathen SA
Find a price of Fluvastatin Sodium bulk with DMF offered by Pharmathen SA
Find a price of Paliperidone bulk with DMF offered by Pharmathen SA
Find a price of Valganciclovir Hydrochloride bulk with DMF offered by Pharmathen SA
Find a price of Voriconazole bulk with DMF offered by Pharmathen SA
LOOKING FOR A SUPPLIER?